For decades, the Left has been championing the invasion of illegal aliens and migrants while ignoring the serious diseases and ailments they bring with them when they cross the borders into the United States and in countries around the world.
While our government is firing US border agents for refusing to accept the COVID jab, unvaccinated illegal aliens and migrants are allowed to walk freely across our borders. In America, unvaccinated illegal aliens are being loaded on planes and buses across America with no concern for their fellow passengers or for the citizens in the cities and communities where they’re being shipped.
What they’re doing is 100% treason. https://t.co/cwdAHg6QYT
— Robby Starbuck (@robbystarbuck) December 19, 2021
Meanwhile, in nations around the world, tens of millions of migrants who could be vaccinated are not getting the jab. It’s not because the COVID vaccines aren’t available—it’s because the manufacturers of the vaccines are unwilling to assume the legal risks associated with the harmful side effects from their COVID vaccines.
Should this concern individuals who are being forced to take the COVID jab in America and other countries where vaccine manufacturers are provided immunity from being sued over harmful or even fatal side effects?
Reuters reports – Many COVID-19 vaccine manufacturers have required that countries indemnify them for any adverse events suffered by individuals as a result of the vaccines, the United Nations says.
Gavi, which operates COVAX with the World Health Organization (WHO), says that where those applying for doses, mainly NGOs, can’t bear legal risks, deliveries from that stockpile can only be made if vaccine-makers accept liability.
Deliveries from the #COVAX Humanitarian Buffer can only be carried out if manufacturers accept liability. We reiterate our call for all manufacturers to choose global solidarity over technicalities to protect some of the world’s most vulnerable people: https://t.co/fsk63nIFaR
— Seth Berkley (@GaviSeth) December 16, 2021
The companies that are willing to do so under these circumstances provide only a minority of the program’s vaccines, according to people familiar with the matter and the documents, written by Gavi staff for a board meeting starting at the end of November.
Mainly because of the legal concerns, less than 2 million doses have so far been sent from the buffer, Gavi says. About 167 million people risk being excluded from national programs, according to United Nations data cited in the documents.
Unless all the firms accept legal liability, “access to vaccines for some populations will remain a challenge,” the Gavi documents say, adding that new crises will generate additional demand to cover displaced populations.
The vaccine makers’ reluctance to take on the legal risks is “a major hurdle” in attempts to provide vaccines for the buffer, a spokesperson for Gavi told Reuters. Gavi did not comment on the details in the documents but said applications for vaccines are confidential until the doses are delivered. In September, Gavi’s CEO, Seth Berkley, tweeted an appeal to drugmakers to waive their requirements for legal indemnity.
The global industry association, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), said “no company has refused to consider” taking on the legal risk. However, in the case of shots delivered from the buffer, it said some firms felt they could not do so without full knowledge of where and how vaccines would be used.
It would be hard to continuously monitor vaccines for safety in refugee camps, and delivery is logistically very challenging and not suitable for all types, said the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents large pharmaceutical companies in Europe.
People may blame vaccines for problems that emerge afterward, even if they are unrelated, it said.
“This could then lead to an increased number of litigation cases … during which the safety and efficacy of the vaccine would be publicly questioned,” it said in a statement to Reuters. That might lead to increased vaccine hesitancy and a slower recovery from the pandemic, it said.
NEED FOR SPEED
The vaccine makers’ legal concern is rooted in the unprecedented speed of the effort to develop the COVID shots, the EFPIA said.
In normal circumstances, drugmakers buy insurance to cover liability for vaccines’ potential adverse effects. But COVID forced them to develop drugs so quickly that some side effects – for instance, a rare blood-clotting condition in some of those who took the AstraZeneca vaccine – are emerging as shots go into people’s arms.